Two of the world’s largest life sciences companies have expanded their previously announced partnership to produce advanced medicines in North Carolina. FUJIFILM Biotechnologies was featured in a recent CNBC story on the company's new facilities. The investments will enable J&J to manufacture “the vast majority” of its advanced medicines in the U.S. to meet the needs of U.S. patients. An aerial image of FUJIFILM Biotechnologies facility in Holly Springs. Meanwhile, progress continues in the construction of J&J’s new biologics manufacturing facility in Wilson, 50 miles east of Raleigh.